Covid-19 Impact on Global Intravenous (IV) Ibuprofen Market Insights, Forecast to 2026
Intravenous (IV) Ibuprofen market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravenous (IV) Ibuprofen market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Intravenous (IV) Ibuprofen market is segmented into
Regional and Country-level Analysis
The Intravenous (IV) Ibuprofen market is analysed and market size information is provided by regions (countries).
The key regions covered in the Intravenous (IV) Ibuprofen market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Intravenous (IV) Ibuprofen Market Share Analysis
Intravenous (IV) Ibuprofen market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intravenous (IV) Ibuprofen business, the date to enter into the Intravenous (IV) Ibuprofen market, Intravenous (IV) Ibuprofen product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the Intravenous (IV) Ibuprofen market is segmented into
- 100 mg Dose
- 200 mg Dose
- 400 mg Dose
- 800 mg Dose
- Pain
- Fever
- Inflammation
Regional and Country-level Analysis
The Intravenous (IV) Ibuprofen market is analysed and market size information is provided by regions (countries).
The key regions covered in the Intravenous (IV) Ibuprofen market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Intravenous (IV) Ibuprofen Market Share Analysis
Intravenous (IV) Ibuprofen market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Intravenous (IV) Ibuprofen business, the date to enter into the Intravenous (IV) Ibuprofen market, Intravenous (IV) Ibuprofen product introduction, recent developments, etc.
The major vendors covered:
- Cumberland Pharmaceuticals
- Alveda Pharmaceuticals
- CSL Limited
- Sandor Medicaids
- PT. Soho Industri Pharmasi
- Germin MED
- Grifols
- Gloria Pharmaceuticals
- Al Nabeel International
- Laboratorios Valmorca
1 STUDY COVERAGE
1.1 Intravenous (IV) Ibuprofen Product Introduction
1.2 Market Segments
1.3 Key Intravenous (IV) Ibuprofen Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Type
1.4.2 100 mg Dose
1.4.3 200 mg Dose
1.4.4 400 mg Dose
1.4.5 800 mg Dose
1.5 Market by Application
1.5.1 Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Application
1.5.2 Pain
1.5.3 Fever
1.5.4 Inflammation
1.6 Coronavirus Disease 2019 (Covid-19): Intravenous (IV) Ibuprofen Industry Impact
1.6.1 How the Covid-19 is Affecting the Intravenous (IV) Ibuprofen Industry
1.6.1.1 Intravenous (IV) Ibuprofen Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Intravenous (IV) Ibuprofen Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Intravenous (IV) Ibuprofen Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Intravenous (IV) Ibuprofen Market Size Estimates and Forecasts
2.1.1 Global Intravenous (IV) Ibuprofen Revenue 2015-2026
2.1.2 Global Intravenous (IV) Ibuprofen Sales 2015-2026
2.2 Intravenous (IV) Ibuprofen Market Size by Region: 2020 Versus 2026
2.2.1 Global Intravenous (IV) Ibuprofen Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Intravenous (IV) Ibuprofen Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL INTRAVENOUS (IV) IBUPROFEN COMPETITOR LANDSCAPE BY PLAYERS
3.1 Intravenous (IV) Ibuprofen Sales by Manufacturers
3.1.1 Intravenous (IV) Ibuprofen Sales by Manufacturers (2015-2020)
3.1.2 Intravenous (IV) Ibuprofen Sales Market Share by Manufacturers (2015-2020)
3.2 Intravenous (IV) Ibuprofen Revenue by Manufacturers
3.2.1 Intravenous (IV) Ibuprofen Revenue by Manufacturers (2015-2020)
3.2.2 Intravenous (IV) Ibuprofen Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Intravenous (IV) Ibuprofen Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Intravenous (IV) Ibuprofen Revenue in 2019
3.2.5 Global Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Intravenous (IV) Ibuprofen Price by Manufacturers
3.4 Intravenous (IV) Ibuprofen Manufacturing Base Distribution, Product Types
3.4.1 Intravenous (IV) Ibuprofen Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intravenous (IV) Ibuprofen Product Type
3.4.3 Date of International Manufacturers Enter into Intravenous (IV) Ibuprofen Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Intravenous (IV) Ibuprofen Market Size by Type (2015-2020)
4.1.1 Global Intravenous (IV) Ibuprofen Sales by Type (2015-2020)
4.1.2 Global Intravenous (IV) Ibuprofen Revenue by Type (2015-2020)
4.1.3 Intravenous (IV) Ibuprofen Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Intravenous (IV) Ibuprofen Market Size Forecast by Type (2021-2026)
4.2.1 Global Intravenous (IV) Ibuprofen Sales Forecast by Type (2021-2026)
4.2.2 Global Intravenous (IV) Ibuprofen Revenue Forecast by Type (2021-2026)
4.2.3 Intravenous (IV) Ibuprofen Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Intravenous (IV) Ibuprofen Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Intravenous (IV) Ibuprofen Market Size by Application (2015-2020)
5.1.1 Global Intravenous (IV) Ibuprofen Sales by Application (2015-2020)
5.1.2 Global Intravenous (IV) Ibuprofen Revenue by Application (2015-2020)
5.1.3 Intravenous (IV) Ibuprofen Price by Application (2015-2020)
5.2 Intravenous (IV) Ibuprofen Market Size Forecast by Application (2021-2026)
5.2.1 Global Intravenous (IV) Ibuprofen Sales Forecast by Application (2021-2026)
5.2.2 Global Intravenous (IV) Ibuprofen Revenue Forecast by Application (2021-2026)
5.2.3 Global Intravenous (IV) Ibuprofen Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Intravenous (IV) Ibuprofen by Country
6.1.1 North America Intravenous (IV) Ibuprofen Sales by Country
6.1.2 North America Intravenous (IV) Ibuprofen Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Intravenous (IV) Ibuprofen Market Facts & Figures by Type
6.3 North America Intravenous (IV) Ibuprofen Market Facts & Figures by Application
7 EUROPE
7.1 Europe Intravenous (IV) Ibuprofen by Country
7.1.1 Europe Intravenous (IV) Ibuprofen Sales by Country
7.1.2 Europe Intravenous (IV) Ibuprofen Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intravenous (IV) Ibuprofen Market Facts & Figures by Type
7.3 Europe Intravenous (IV) Ibuprofen Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Intravenous (IV) Ibuprofen by Region
8.1.1 Asia Pacific Intravenous (IV) Ibuprofen Sales by Region
8.1.2 Asia Pacific Intravenous (IV) Ibuprofen Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Intravenous (IV) Ibuprofen Market Facts & Figures by Type
8.3 Asia Pacific Intravenous (IV) Ibuprofen Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Intravenous (IV) Ibuprofen by Country
9.1.1 Latin America Intravenous (IV) Ibuprofen Sales by Country
9.1.2 Latin America Intravenous (IV) Ibuprofen Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Intravenous (IV) Ibuprofen Market Facts & Figures by Type
9.3 Central & South America Intravenous (IV) Ibuprofen Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Intravenous (IV) Ibuprofen by Country
10.1.1 Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country
10.1.2 Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Intravenous (IV) Ibuprofen Market Facts & Figures by Type
10.3 Middle East and Africa Intravenous (IV) Ibuprofen Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Cumberland Pharmaceuticals
11.1.1 Cumberland Pharmaceuticals Corporation Information
11.1.2 Cumberland Pharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Cumberland Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
11.1.5 Cumberland Pharmaceuticals Recent Development
11.2 Alveda Pharmaceuticals
11.2.1 Alveda Pharmaceuticals Corporation Information
11.2.2 Alveda Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 Alveda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
11.2.5 Alveda Pharmaceuticals Recent Development
11.3 CSL Limited
11.3.1 CSL Limited Corporation Information
11.3.2 CSL Limited Description, Business Overview and Total Revenue
11.3.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Limited Intravenous (IV) Ibuprofen Products Offered
11.3.5 CSL Limited Recent Development
11.4 Sandor Medicaids
11.4.1 Sandor Medicaids Corporation Information
11.4.2 Sandor Medicaids Description, Business Overview and Total Revenue
11.4.3 Sandor Medicaids Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sandor Medicaids Intravenous (IV) Ibuprofen Products Offered
11.4.5 Sandor Medicaids Recent Development
11.5 PT. Soho Industri Pharmasi
11.5.1 PT. Soho Industri Pharmasi Corporation Information
11.5.2 PT. Soho Industri Pharmasi Description, Business Overview and Total Revenue
11.5.3 PT. Soho Industri Pharmasi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Products Offered
11.5.5 PT. Soho Industri Pharmasi Recent Development
11.6 Germin MED
11.6.1 Germin MED Corporation Information
11.6.2 Germin MED Description, Business Overview and Total Revenue
11.6.3 Germin MED Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Germin MED Intravenous (IV) Ibuprofen Products Offered
11.6.5 Germin MED Recent Development
11.7 Grifols
11.7.1 Grifols Corporation Information
11.7.2 Grifols Description, Business Overview and Total Revenue
11.7.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Grifols Intravenous (IV) Ibuprofen Products Offered
11.7.5 Grifols Recent Development
11.8 Gloria Pharmaceuticals
11.8.1 Gloria Pharmaceuticals Corporation Information
11.8.2 Gloria Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 Gloria Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
11.8.5 Gloria Pharmaceuticals Recent Development
11.9 Al Nabeel International
11.9.1 Al Nabeel International Corporation Information
11.9.2 Al Nabeel International Description, Business Overview and Total Revenue
11.9.3 Al Nabeel International Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Al Nabeel International Intravenous (IV) Ibuprofen Products Offered
11.9.5 Al Nabeel International Recent Development
11.10 Laboratorios Valmorca
11.10.1 Laboratorios Valmorca Corporation Information
11.10.2 Laboratorios Valmorca Description, Business Overview and Total Revenue
11.10.3 Laboratorios Valmorca Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Laboratorios Valmorca Intravenous (IV) Ibuprofen Products Offered
11.10.5 Laboratorios Valmorca Recent Development
11.1 Cumberland Pharmaceuticals
11.1.1 Cumberland Pharmaceuticals Corporation Information
11.1.2 Cumberland Pharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Cumberland Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
11.1.5 Cumberland Pharmaceuticals Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Intravenous (IV) Ibuprofen Market Estimates and Projections by Region
12.1.1 Global Intravenous (IV) Ibuprofen Sales Forecast by Regions 2021-2026
12.1.2 Global Intravenous (IV) Ibuprofen Revenue Forecast by Regions 2021-2026
12.2 North America Intravenous (IV) Ibuprofen Market Size Forecast (2021-2026)
12.2.1 North America: Intravenous (IV) Ibuprofen Sales Forecast (2021-2026)
12.2.2 North America: Intravenous (IV) Ibuprofen Revenue Forecast (2021-2026)
12.2.3 North America: Intravenous (IV) Ibuprofen Market Size Forecast by Country (2021-2026)
12.3 Europe Intravenous (IV) Ibuprofen Market Size Forecast (2021-2026)
12.3.1 Europe: Intravenous (IV) Ibuprofen Sales Forecast (2021-2026)
12.3.2 Europe: Intravenous (IV) Ibuprofen Revenue Forecast (2021-2026)
12.3.3 Europe: Intravenous (IV) Ibuprofen Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Intravenous (IV) Ibuprofen Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Intravenous (IV) Ibuprofen Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Intravenous (IV) Ibuprofen Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Intravenous (IV) Ibuprofen Market Size Forecast by Region (2021-2026)
12.5 Latin America Intravenous (IV) Ibuprofen Market Size Forecast (2021-2026)
12.5.1 Latin America: Intravenous (IV) Ibuprofen Sales Forecast (2021-2026)
12.5.2 Latin America: Intravenous (IV) Ibuprofen Revenue Forecast (2021-2026)
12.5.3 Latin America: Intravenous (IV) Ibuprofen Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Intravenous (IV) Ibuprofen Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Intravenous (IV) Ibuprofen Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Intravenous (IV) Ibuprofen Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Intravenous (IV) Ibuprofen Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Intravenous (IV) Ibuprofen Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Intravenous (IV) Ibuprofen Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 Intravenous (IV) Ibuprofen Product Introduction
1.2 Market Segments
1.3 Key Intravenous (IV) Ibuprofen Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Type
1.4.2 100 mg Dose
1.4.3 200 mg Dose
1.4.4 400 mg Dose
1.4.5 800 mg Dose
1.5 Market by Application
1.5.1 Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Application
1.5.2 Pain
1.5.3 Fever
1.5.4 Inflammation
1.6 Coronavirus Disease 2019 (Covid-19): Intravenous (IV) Ibuprofen Industry Impact
1.6.1 How the Covid-19 is Affecting the Intravenous (IV) Ibuprofen Industry
1.6.1.1 Intravenous (IV) Ibuprofen Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Intravenous (IV) Ibuprofen Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Intravenous (IV) Ibuprofen Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Intravenous (IV) Ibuprofen Market Size Estimates and Forecasts
2.1.1 Global Intravenous (IV) Ibuprofen Revenue 2015-2026
2.1.2 Global Intravenous (IV) Ibuprofen Sales 2015-2026
2.2 Intravenous (IV) Ibuprofen Market Size by Region: 2020 Versus 2026
2.2.1 Global Intravenous (IV) Ibuprofen Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Intravenous (IV) Ibuprofen Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL INTRAVENOUS (IV) IBUPROFEN COMPETITOR LANDSCAPE BY PLAYERS
3.1 Intravenous (IV) Ibuprofen Sales by Manufacturers
3.1.1 Intravenous (IV) Ibuprofen Sales by Manufacturers (2015-2020)
3.1.2 Intravenous (IV) Ibuprofen Sales Market Share by Manufacturers (2015-2020)
3.2 Intravenous (IV) Ibuprofen Revenue by Manufacturers
3.2.1 Intravenous (IV) Ibuprofen Revenue by Manufacturers (2015-2020)
3.2.2 Intravenous (IV) Ibuprofen Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Intravenous (IV) Ibuprofen Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Intravenous (IV) Ibuprofen Revenue in 2019
3.2.5 Global Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Intravenous (IV) Ibuprofen Price by Manufacturers
3.4 Intravenous (IV) Ibuprofen Manufacturing Base Distribution, Product Types
3.4.1 Intravenous (IV) Ibuprofen Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Intravenous (IV) Ibuprofen Product Type
3.4.3 Date of International Manufacturers Enter into Intravenous (IV) Ibuprofen Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Intravenous (IV) Ibuprofen Market Size by Type (2015-2020)
4.1.1 Global Intravenous (IV) Ibuprofen Sales by Type (2015-2020)
4.1.2 Global Intravenous (IV) Ibuprofen Revenue by Type (2015-2020)
4.1.3 Intravenous (IV) Ibuprofen Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Intravenous (IV) Ibuprofen Market Size Forecast by Type (2021-2026)
4.2.1 Global Intravenous (IV) Ibuprofen Sales Forecast by Type (2021-2026)
4.2.2 Global Intravenous (IV) Ibuprofen Revenue Forecast by Type (2021-2026)
4.2.3 Intravenous (IV) Ibuprofen Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Intravenous (IV) Ibuprofen Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Intravenous (IV) Ibuprofen Market Size by Application (2015-2020)
5.1.1 Global Intravenous (IV) Ibuprofen Sales by Application (2015-2020)
5.1.2 Global Intravenous (IV) Ibuprofen Revenue by Application (2015-2020)
5.1.3 Intravenous (IV) Ibuprofen Price by Application (2015-2020)
5.2 Intravenous (IV) Ibuprofen Market Size Forecast by Application (2021-2026)
5.2.1 Global Intravenous (IV) Ibuprofen Sales Forecast by Application (2021-2026)
5.2.2 Global Intravenous (IV) Ibuprofen Revenue Forecast by Application (2021-2026)
5.2.3 Global Intravenous (IV) Ibuprofen Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Intravenous (IV) Ibuprofen by Country
6.1.1 North America Intravenous (IV) Ibuprofen Sales by Country
6.1.2 North America Intravenous (IV) Ibuprofen Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Intravenous (IV) Ibuprofen Market Facts & Figures by Type
6.3 North America Intravenous (IV) Ibuprofen Market Facts & Figures by Application
7 EUROPE
7.1 Europe Intravenous (IV) Ibuprofen by Country
7.1.1 Europe Intravenous (IV) Ibuprofen Sales by Country
7.1.2 Europe Intravenous (IV) Ibuprofen Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Intravenous (IV) Ibuprofen Market Facts & Figures by Type
7.3 Europe Intravenous (IV) Ibuprofen Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific Intravenous (IV) Ibuprofen by Region
8.1.1 Asia Pacific Intravenous (IV) Ibuprofen Sales by Region
8.1.2 Asia Pacific Intravenous (IV) Ibuprofen Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Intravenous (IV) Ibuprofen Market Facts & Figures by Type
8.3 Asia Pacific Intravenous (IV) Ibuprofen Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America Intravenous (IV) Ibuprofen by Country
9.1.1 Latin America Intravenous (IV) Ibuprofen Sales by Country
9.1.2 Latin America Intravenous (IV) Ibuprofen Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Intravenous (IV) Ibuprofen Market Facts & Figures by Type
9.3 Central & South America Intravenous (IV) Ibuprofen Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa Intravenous (IV) Ibuprofen by Country
10.1.1 Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country
10.1.2 Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Intravenous (IV) Ibuprofen Market Facts & Figures by Type
10.3 Middle East and Africa Intravenous (IV) Ibuprofen Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Cumberland Pharmaceuticals
11.1.1 Cumberland Pharmaceuticals Corporation Information
11.1.2 Cumberland Pharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Cumberland Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
11.1.5 Cumberland Pharmaceuticals Recent Development
11.2 Alveda Pharmaceuticals
11.2.1 Alveda Pharmaceuticals Corporation Information
11.2.2 Alveda Pharmaceuticals Description, Business Overview and Total Revenue
11.2.3 Alveda Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
11.2.5 Alveda Pharmaceuticals Recent Development
11.3 CSL Limited
11.3.1 CSL Limited Corporation Information
11.3.2 CSL Limited Description, Business Overview and Total Revenue
11.3.3 CSL Limited Sales, Revenue and Gross Margin (2015-2020)
11.3.4 CSL Limited Intravenous (IV) Ibuprofen Products Offered
11.3.5 CSL Limited Recent Development
11.4 Sandor Medicaids
11.4.1 Sandor Medicaids Corporation Information
11.4.2 Sandor Medicaids Description, Business Overview and Total Revenue
11.4.3 Sandor Medicaids Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sandor Medicaids Intravenous (IV) Ibuprofen Products Offered
11.4.5 Sandor Medicaids Recent Development
11.5 PT. Soho Industri Pharmasi
11.5.1 PT. Soho Industri Pharmasi Corporation Information
11.5.2 PT. Soho Industri Pharmasi Description, Business Overview and Total Revenue
11.5.3 PT. Soho Industri Pharmasi Sales, Revenue and Gross Margin (2015-2020)
11.5.4 PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Products Offered
11.5.5 PT. Soho Industri Pharmasi Recent Development
11.6 Germin MED
11.6.1 Germin MED Corporation Information
11.6.2 Germin MED Description, Business Overview and Total Revenue
11.6.3 Germin MED Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Germin MED Intravenous (IV) Ibuprofen Products Offered
11.6.5 Germin MED Recent Development
11.7 Grifols
11.7.1 Grifols Corporation Information
11.7.2 Grifols Description, Business Overview and Total Revenue
11.7.3 Grifols Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Grifols Intravenous (IV) Ibuprofen Products Offered
11.7.5 Grifols Recent Development
11.8 Gloria Pharmaceuticals
11.8.1 Gloria Pharmaceuticals Corporation Information
11.8.2 Gloria Pharmaceuticals Description, Business Overview and Total Revenue
11.8.3 Gloria Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
11.8.5 Gloria Pharmaceuticals Recent Development
11.9 Al Nabeel International
11.9.1 Al Nabeel International Corporation Information
11.9.2 Al Nabeel International Description, Business Overview and Total Revenue
11.9.3 Al Nabeel International Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Al Nabeel International Intravenous (IV) Ibuprofen Products Offered
11.9.5 Al Nabeel International Recent Development
11.10 Laboratorios Valmorca
11.10.1 Laboratorios Valmorca Corporation Information
11.10.2 Laboratorios Valmorca Description, Business Overview and Total Revenue
11.10.3 Laboratorios Valmorca Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Laboratorios Valmorca Intravenous (IV) Ibuprofen Products Offered
11.10.5 Laboratorios Valmorca Recent Development
11.1 Cumberland Pharmaceuticals
11.1.1 Cumberland Pharmaceuticals Corporation Information
11.1.2 Cumberland Pharmaceuticals Description, Business Overview and Total Revenue
11.1.3 Cumberland Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Products Offered
11.1.5 Cumberland Pharmaceuticals Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 Intravenous (IV) Ibuprofen Market Estimates and Projections by Region
12.1.1 Global Intravenous (IV) Ibuprofen Sales Forecast by Regions 2021-2026
12.1.2 Global Intravenous (IV) Ibuprofen Revenue Forecast by Regions 2021-2026
12.2 North America Intravenous (IV) Ibuprofen Market Size Forecast (2021-2026)
12.2.1 North America: Intravenous (IV) Ibuprofen Sales Forecast (2021-2026)
12.2.2 North America: Intravenous (IV) Ibuprofen Revenue Forecast (2021-2026)
12.2.3 North America: Intravenous (IV) Ibuprofen Market Size Forecast by Country (2021-2026)
12.3 Europe Intravenous (IV) Ibuprofen Market Size Forecast (2021-2026)
12.3.1 Europe: Intravenous (IV) Ibuprofen Sales Forecast (2021-2026)
12.3.2 Europe: Intravenous (IV) Ibuprofen Revenue Forecast (2021-2026)
12.3.3 Europe: Intravenous (IV) Ibuprofen Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Intravenous (IV) Ibuprofen Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Intravenous (IV) Ibuprofen Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Intravenous (IV) Ibuprofen Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Intravenous (IV) Ibuprofen Market Size Forecast by Region (2021-2026)
12.5 Latin America Intravenous (IV) Ibuprofen Market Size Forecast (2021-2026)
12.5.1 Latin America: Intravenous (IV) Ibuprofen Sales Forecast (2021-2026)
12.5.2 Latin America: Intravenous (IV) Ibuprofen Revenue Forecast (2021-2026)
12.5.3 Latin America: Intravenous (IV) Ibuprofen Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Intravenous (IV) Ibuprofen Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Intravenous (IV) Ibuprofen Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Intravenous (IV) Ibuprofen Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Intravenous (IV) Ibuprofen Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Intravenous (IV) Ibuprofen Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 Intravenous (IV) Ibuprofen Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. Intravenous (IV) Ibuprofen Market Segments
Table 2. Ranking of Global Top Intravenous (IV) Ibuprofen Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of 100 mg Dose
Table 5. Major Manufacturers of 200 mg Dose
Table 6. Major Manufacturers of 400 mg Dose
Table 7. Major Manufacturers of 800 mg Dose
Table 8. COVID-19 Impact Global Market: (Four Intravenous (IV) Ibuprofen Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Intravenous (IV) Ibuprofen Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Intravenous (IV) Ibuprofen Players to Combat Covid-19 Impact
Table 13. Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Application 2020-2026 (MT)
Table 14. Global Intravenous (IV) Ibuprofen Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 15. Global Intravenous (IV) Ibuprofen Sales by Regions 2015-2020 (MT)
Table 16. Global Intravenous (IV) Ibuprofen Sales Market Share by Regions (2015-2020)
Table 17. Global Intravenous (IV) Ibuprofen Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Intravenous (IV) Ibuprofen Sales by Manufacturers (2015-2020) (MT)
Table 19. Global Intravenous (IV) Ibuprofen Sales Share by Manufacturers (2015-2020)
Table 20. Global Intravenous (IV) Ibuprofen Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Intravenous (IV) Ibuprofen by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Ibuprofen as of 2019)
Table 22. Intravenous (IV) Ibuprofen Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Intravenous (IV) Ibuprofen Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Intravenous (IV) Ibuprofen Price (2015-2020) (USD/Kg)
Table 25. Intravenous (IV) Ibuprofen Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Intravenous (IV) Ibuprofen Product Type
Table 27. Date of International Manufacturers Enter into Intravenous (IV) Ibuprofen Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 30. Global Intravenous (IV) Ibuprofen Sales Share by Type (2015-2020)
Table 31. Global Intravenous (IV) Ibuprofen Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Intravenous (IV) Ibuprofen Revenue Share by Type (2015-2020)
Table 33. Intravenous (IV) Ibuprofen Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 34. Global Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 35. Global Intravenous (IV) Ibuprofen Sales Share by Application (2015-2020)
Table 36. North America Intravenous (IV) Ibuprofen Sales by Country (2015-2020) (MT)
Table 37. North America Intravenous (IV) Ibuprofen Sales Market Share by Country (2015-2020)
Table 38. North America Intravenous (IV) Ibuprofen Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Intravenous (IV) Ibuprofen Revenue Market Share by Country (2015-2020)
Table 40. North America Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 41. North America Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Table 42. North America Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 43. North America Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Table 44. Europe Intravenous (IV) Ibuprofen Sales by Country (2015-2020) (MT)
Table 45. Europe Intravenous (IV) Ibuprofen Sales Market Share by Country (2015-2020)
Table 46. Europe Intravenous (IV) Ibuprofen Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Intravenous (IV) Ibuprofen Revenue Market Share by Country (2015-2020)
Table 48. Europe Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 49. Europe Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Table 50. Europe Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 51. Europe Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Intravenous (IV) Ibuprofen Sales by Region (2015-2020) (MT)
Table 53. Asia Pacific Intravenous (IV) Ibuprofen Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Intravenous (IV) Ibuprofen Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Intravenous (IV) Ibuprofen Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 57. Asia Pacific Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 59. Asia Pacific Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Table 60. Latin America Intravenous (IV) Ibuprofen Sales by Country (2015-2020) (MT)
Table 61. Latin America Intravenous (IV) Ibuprofen Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Intravenous (IV) Ibuprofen Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Intravenous (IV) Ibuprofen Revenue Market Share by Country (2015-2020)
Table 64. Latin America Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 65. Latin America Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Table 66. Latin America Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 67. Latin America Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2015-2020) (MT)
Table 69. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 73. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 75. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Table 76. Cumberland Pharmaceuticals Corporation Information
Table 77. Cumberland Pharmaceuticals Description and Major Businesses
Table 78. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 79. Cumberland Pharmaceuticals Product
Table 80. Cumberland Pharmaceuticals Recent Development
Table 81. Alveda Pharmaceuticals Corporation Information
Table 82. Alveda Pharmaceuticals Description and Major Businesses
Table 83. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 84. Alveda Pharmaceuticals Product
Table 85. Alveda Pharmaceuticals Recent Development
Table 86. CSL Limited Corporation Information
Table 87. CSL Limited Description and Major Businesses
Table 88. CSL Limited Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 89. CSL Limited Product
Table 90. CSL Limited Recent Development
Table 91. Sandor Medicaids Corporation Information
Table 92. Sandor Medicaids Description and Major Businesses
Table 93. Sandor Medicaids Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 94. Sandor Medicaids Product
Table 95. Sandor Medicaids Recent Development
Table 96. PT. Soho Industri Pharmasi Corporation Information
Table 97. PT. Soho Industri Pharmasi Description and Major Businesses
Table 98. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 99. PT. Soho Industri Pharmasi Product
Table 100. PT. Soho Industri Pharmasi Recent Development
Table 101. Germin MED Corporation Information
Table 102. Germin MED Description and Major Businesses
Table 103. Germin MED Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 104. Germin MED Product
Table 105. Germin MED Recent Development
Table 106. Grifols Corporation Information
Table 107. Grifols Description and Major Businesses
Table 108. Grifols Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 109. Grifols Product
Table 110. Grifols Recent Development
Table 111. Gloria Pharmaceuticals Corporation Information
Table 112. Gloria Pharmaceuticals Description and Major Businesses
Table 113. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 114. Gloria Pharmaceuticals Product
Table 115. Gloria Pharmaceuticals Recent Development
Table 116. Al Nabeel International Corporation Information
Table 117. Al Nabeel International Description and Major Businesses
Table 118. Al Nabeel International Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 119. Al Nabeel International Product
Table 120. Al Nabeel International Recent Development
Table 121. Laboratorios Valmorca Corporation Information
Table 122. Laboratorios Valmorca Description and Major Businesses
Table 123. Laboratorios Valmorca Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 124. Laboratorios Valmorca Product
Table 125. Laboratorios Valmorca Recent Development
Table 126. Global Intravenous (IV) Ibuprofen Sales Forecast by Regions (2021-2026) (MT)
Table 127. Global Intravenous (IV) Ibuprofen Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Intravenous (IV) Ibuprofen Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Intravenous (IV) Ibuprofen Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Intravenous (IV) Ibuprofen Sales Forecast by Country (2021-2026) (MT)
Table 131. North America: Intravenous (IV) Ibuprofen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Intravenous (IV) Ibuprofen Sales Forecast by Country (2021-2026) (MT)
Table 133. Europe: Intravenous (IV) Ibuprofen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Intravenous (IV) Ibuprofen Sales Forecast by Region (2021-2026) (MT)
Table 135. Asia Pacific: Intravenous (IV) Ibuprofen Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Intravenous (IV) Ibuprofen Sales Forecast by Country (2021-2026) (MT)
Table 137. Latin America: Intravenous (IV) Ibuprofen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Intravenous (IV) Ibuprofen Sales Forecast by Country (2021-2026) (MT)
Table 139. Middle East and Africa: Intravenous (IV) Ibuprofen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Intravenous (IV) Ibuprofen Players
Table 144. Intravenous (IV) Ibuprofen Customers List
Table 145. Intravenous (IV) Ibuprofen Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
Table 1. Intravenous (IV) Ibuprofen Market Segments
Table 2. Ranking of Global Top Intravenous (IV) Ibuprofen Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of 100 mg Dose
Table 5. Major Manufacturers of 200 mg Dose
Table 6. Major Manufacturers of 400 mg Dose
Table 7. Major Manufacturers of 800 mg Dose
Table 8. COVID-19 Impact Global Market: (Four Intravenous (IV) Ibuprofen Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Intravenous (IV) Ibuprofen Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Intravenous (IV) Ibuprofen Players to Combat Covid-19 Impact
Table 13. Global Intravenous (IV) Ibuprofen Market Size Growth Rate by Application 2020-2026 (MT)
Table 14. Global Intravenous (IV) Ibuprofen Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 15. Global Intravenous (IV) Ibuprofen Sales by Regions 2015-2020 (MT)
Table 16. Global Intravenous (IV) Ibuprofen Sales Market Share by Regions (2015-2020)
Table 17. Global Intravenous (IV) Ibuprofen Revenue by Regions 2015-2020 (US$ Million)
Table 18. Global Intravenous (IV) Ibuprofen Sales by Manufacturers (2015-2020) (MT)
Table 19. Global Intravenous (IV) Ibuprofen Sales Share by Manufacturers (2015-2020)
Table 20. Global Intravenous (IV) Ibuprofen Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 21. Global Intravenous (IV) Ibuprofen by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous (IV) Ibuprofen as of 2019)
Table 22. Intravenous (IV) Ibuprofen Revenue by Manufacturers (2015-2020) (US$ Million)
Table 23. Intravenous (IV) Ibuprofen Revenue Share by Manufacturers (2015-2020)
Table 24. Key Manufacturers Intravenous (IV) Ibuprofen Price (2015-2020) (USD/Kg)
Table 25. Intravenous (IV) Ibuprofen Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Intravenous (IV) Ibuprofen Product Type
Table 27. Date of International Manufacturers Enter into Intravenous (IV) Ibuprofen Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 30. Global Intravenous (IV) Ibuprofen Sales Share by Type (2015-2020)
Table 31. Global Intravenous (IV) Ibuprofen Revenue by Type (2015-2020) (US$ Million)
Table 32. Global Intravenous (IV) Ibuprofen Revenue Share by Type (2015-2020)
Table 33. Intravenous (IV) Ibuprofen Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 34. Global Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 35. Global Intravenous (IV) Ibuprofen Sales Share by Application (2015-2020)
Table 36. North America Intravenous (IV) Ibuprofen Sales by Country (2015-2020) (MT)
Table 37. North America Intravenous (IV) Ibuprofen Sales Market Share by Country (2015-2020)
Table 38. North America Intravenous (IV) Ibuprofen Revenue by Country (2015-2020) (US$ Million)
Table 39. North America Intravenous (IV) Ibuprofen Revenue Market Share by Country (2015-2020)
Table 40. North America Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 41. North America Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Table 42. North America Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 43. North America Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Table 44. Europe Intravenous (IV) Ibuprofen Sales by Country (2015-2020) (MT)
Table 45. Europe Intravenous (IV) Ibuprofen Sales Market Share by Country (2015-2020)
Table 46. Europe Intravenous (IV) Ibuprofen Revenue by Country (2015-2020) (US$ Million)
Table 47. Europe Intravenous (IV) Ibuprofen Revenue Market Share by Country (2015-2020)
Table 48. Europe Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 49. Europe Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Table 50. Europe Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 51. Europe Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Table 52. Asia Pacific Intravenous (IV) Ibuprofen Sales by Region (2015-2020) (MT)
Table 53. Asia Pacific Intravenous (IV) Ibuprofen Sales Market Share by Region (2015-2020)
Table 54. Asia Pacific Intravenous (IV) Ibuprofen Revenue by Region (2015-2020) (US$ Million)
Table 55. Asia Pacific Intravenous (IV) Ibuprofen Revenue Market Share by Region (2015-2020)
Table 56. Asia Pacific Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 57. Asia Pacific Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Table 58. Asia Pacific Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 59. Asia Pacific Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Table 60. Latin America Intravenous (IV) Ibuprofen Sales by Country (2015-2020) (MT)
Table 61. Latin America Intravenous (IV) Ibuprofen Sales Market Share by Country (2015-2020)
Table 62. Latin Americaa Intravenous (IV) Ibuprofen Revenue by Country (2015-2020) (US$ Million)
Table 63. Latin America Intravenous (IV) Ibuprofen Revenue Market Share by Country (2015-2020)
Table 64. Latin America Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 65. Latin America Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Table 66. Latin America Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 67. Latin America Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Table 68. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Country (2015-2020) (MT)
Table 69. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share by Country (2015-2020)
Table 70. Middle East and Africa Intravenous (IV) Ibuprofen Revenue by Country (2015-2020) (US$ Million)
Table 71. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Type (2015-2020) (MT)
Table 73. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Table 74. Middle East and Africa Intravenous (IV) Ibuprofen Sales by Application (2015-2020) (MT)
Table 75. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Table 76. Cumberland Pharmaceuticals Corporation Information
Table 77. Cumberland Pharmaceuticals Description and Major Businesses
Table 78. Cumberland Pharmaceuticals Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 79. Cumberland Pharmaceuticals Product
Table 80. Cumberland Pharmaceuticals Recent Development
Table 81. Alveda Pharmaceuticals Corporation Information
Table 82. Alveda Pharmaceuticals Description and Major Businesses
Table 83. Alveda Pharmaceuticals Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 84. Alveda Pharmaceuticals Product
Table 85. Alveda Pharmaceuticals Recent Development
Table 86. CSL Limited Corporation Information
Table 87. CSL Limited Description and Major Businesses
Table 88. CSL Limited Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 89. CSL Limited Product
Table 90. CSL Limited Recent Development
Table 91. Sandor Medicaids Corporation Information
Table 92. Sandor Medicaids Description and Major Businesses
Table 93. Sandor Medicaids Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 94. Sandor Medicaids Product
Table 95. Sandor Medicaids Recent Development
Table 96. PT. Soho Industri Pharmasi Corporation Information
Table 97. PT. Soho Industri Pharmasi Description and Major Businesses
Table 98. PT. Soho Industri Pharmasi Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 99. PT. Soho Industri Pharmasi Product
Table 100. PT. Soho Industri Pharmasi Recent Development
Table 101. Germin MED Corporation Information
Table 102. Germin MED Description and Major Businesses
Table 103. Germin MED Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 104. Germin MED Product
Table 105. Germin MED Recent Development
Table 106. Grifols Corporation Information
Table 107. Grifols Description and Major Businesses
Table 108. Grifols Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 109. Grifols Product
Table 110. Grifols Recent Development
Table 111. Gloria Pharmaceuticals Corporation Information
Table 112. Gloria Pharmaceuticals Description and Major Businesses
Table 113. Gloria Pharmaceuticals Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 114. Gloria Pharmaceuticals Product
Table 115. Gloria Pharmaceuticals Recent Development
Table 116. Al Nabeel International Corporation Information
Table 117. Al Nabeel International Description and Major Businesses
Table 118. Al Nabeel International Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 119. Al Nabeel International Product
Table 120. Al Nabeel International Recent Development
Table 121. Laboratorios Valmorca Corporation Information
Table 122. Laboratorios Valmorca Description and Major Businesses
Table 123. Laboratorios Valmorca Intravenous (IV) Ibuprofen Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 124. Laboratorios Valmorca Product
Table 125. Laboratorios Valmorca Recent Development
Table 126. Global Intravenous (IV) Ibuprofen Sales Forecast by Regions (2021-2026) (MT)
Table 127. Global Intravenous (IV) Ibuprofen Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Intravenous (IV) Ibuprofen Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Intravenous (IV) Ibuprofen Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Intravenous (IV) Ibuprofen Sales Forecast by Country (2021-2026) (MT)
Table 131. North America: Intravenous (IV) Ibuprofen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Intravenous (IV) Ibuprofen Sales Forecast by Country (2021-2026) (MT)
Table 133. Europe: Intravenous (IV) Ibuprofen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Intravenous (IV) Ibuprofen Sales Forecast by Region (2021-2026) (MT)
Table 135. Asia Pacific: Intravenous (IV) Ibuprofen Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Intravenous (IV) Ibuprofen Sales Forecast by Country (2021-2026) (MT)
Table 137. Latin America: Intravenous (IV) Ibuprofen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Intravenous (IV) Ibuprofen Sales Forecast by Country (2021-2026) (MT)
Table 139. Middle East and Africa: Intravenous (IV) Ibuprofen Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Intravenous (IV) Ibuprofen Players
Table 144. Intravenous (IV) Ibuprofen Customers List
Table 145. Intravenous (IV) Ibuprofen Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Intravenous (IV) Ibuprofen Product Picture
Figure 2. Global Intravenous (IV) Ibuprofen Sales Market Share by Type in 2020 & 2026
Figure 3. 100 mg Dose Product Picture
Figure 4. 200 mg Dose Product Picture
Figure 5. 400 mg Dose Product Picture
Figure 6. 800 mg Dose Product Picture
Figure 7. Global Intravenous (IV) Ibuprofen Sales Market Share by Application in 2020 & 2026
Figure 8. Pain
Figure 9. Fever
Figure 10. Inflammation
Figure 11. Intravenous (IV) Ibuprofen Report Years Considered
Figure 12. Global Intravenous (IV) Ibuprofen Market Size 2015-2026 (US$ Million)
Figure 13. Global Intravenous (IV) Ibuprofen Sales 2015-2026 (MT)
Figure 14. Global Intravenous (IV) Ibuprofen Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Intravenous (IV) Ibuprofen Sales Market Share by Region (2015-2020)
Figure 16. Global Intravenous (IV) Ibuprofen Sales Market Share by Region in 2019
Figure 17. Global Intravenous (IV) Ibuprofen Revenue Market Share by Region (2015-2020)
Figure 18. Global Intravenous (IV) Ibuprofen Revenue Market Share by Region in 2019
Figure 19. Global Intravenous (IV) Ibuprofen Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Intravenous (IV) Ibuprofen Revenue in 2019
Figure 21. Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Figure 23. Global Intravenous (IV) Ibuprofen Sales Market Share by Type in 2019
Figure 24. Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2015-2020)
Figure 25. Global Intravenous (IV) Ibuprofen Revenue Market Share by Type in 2019
Figure 26. Global Intravenous (IV) Ibuprofen Market Share by Price Range (2015-2020)
Figure 27. Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Figure 28. Global Intravenous (IV) Ibuprofen Sales Market Share by Application in 2019
Figure 29. Global Intravenous (IV) Ibuprofen Revenue Market Share by Application (2015-2020)
Figure 30. Global Intravenous (IV) Ibuprofen Revenue Market Share by Application in 2019
Figure 31. North America Intravenous (IV) Ibuprofen Sales Growth Rate 2015-2020 (MT)
Figure 32. North America Intravenous (IV) Ibuprofen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Intravenous (IV) Ibuprofen Sales Market Share by Country in 2019
Figure 34. North America Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2019
Figure 35. U.S. Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 36. U.S. Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 38. Canada Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Intravenous (IV) Ibuprofen Market Share by Type in 2019
Figure 40. North America Intravenous (IV) Ibuprofen Market Share by Application in 2019
Figure 41. Europe Intravenous (IV) Ibuprofen Sales Growth Rate 2015-2020 (MT)
Figure 42. Europe Intravenous (IV) Ibuprofen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Intravenous (IV) Ibuprofen Sales Market Share by Country in 2019
Figure 44. Europe Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2019
Figure 45. Germany Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 46. Germany Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 48. France Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 50. U.K. Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 52. Italy Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 54. Russia Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Intravenous (IV) Ibuprofen Market Share by Type in 2019
Figure 56. Europe Intravenous (IV) Ibuprofen Market Share by Application in 2019
Figure 57. Asia Pacific Intravenous (IV) Ibuprofen Sales Growth Rate 2015-2020 (MT)
Figure 58. Asia Pacific Intravenous (IV) Ibuprofen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Intravenous (IV) Ibuprofen Sales Market Share by Region in 2019
Figure 60. Asia Pacific Intravenous (IV) Ibuprofen Revenue Market Share by Region in 2019
Figure 61. China Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 62. China Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 64. Japan Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 66. South Korea Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 68. India Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 70. Australia Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 72. Taiwan Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 74. Indonesia Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 76. Thailand Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 78. Malaysia Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 80. Philippines Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 82. Vietnam Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Intravenous (IV) Ibuprofen Market Share by Type in 2019
Figure 84. Asia Pacific Intravenous (IV) Ibuprofen Market Share by Application in 2019
Figure 85. Latin America Intravenous (IV) Ibuprofen Sales Growth Rate 2015-2020 (MT)
Figure 86. Latin America Intravenous (IV) Ibuprofen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Intravenous (IV) Ibuprofen Sales Market Share by Country in 2019
Figure 88. Latin America Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2019
Figure 89. Mexico Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 90. Mexico Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 92. Brazil Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 94. Argentina Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Intravenous (IV) Ibuprofen Market Share by Type in 2019
Figure 96. Latin America Intravenous (IV) Ibuprofen Market Share by Application in 2019
Figure 97. Middle East and Africa Intravenous (IV) Ibuprofen Sales Growth Rate 2015-2020 (MT)
Figure 98. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2019
Figure 101. Turkey Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 102. Turkey Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 104. Saudi Arabia Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 106. U.A.E Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Intravenous (IV) Ibuprofen Market Share by Type in 2019
Figure 108. Middle East and Africa Intravenous (IV) Ibuprofen Market Share by Application in 2019
Figure 109. Cumberland Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Alveda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Sandor Medicaids Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. PT. Soho Industri Pharmasi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Germin MED Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Gloria Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Al Nabeel International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Laboratorios Valmorca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Intravenous (IV) Ibuprofen Sales Growth Rate Forecast (2021-2026) (MT)
Figure 120. North America Intravenous (IV) Ibuprofen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Intravenous (IV) Ibuprofen Sales Growth Rate Forecast (2021-2026) (MT)
Figure 122. Europe Intravenous (IV) Ibuprofen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Intravenous (IV) Ibuprofen Sales Growth Rate Forecast (2021-2026) (MT)
Figure 124. Asia Pacific Intravenous (IV) Ibuprofen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Intravenous (IV) Ibuprofen Sales Growth Rate Forecast (2021-2026) (MT)
Figure 126. Latin America Intravenous (IV) Ibuprofen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Intravenous (IV) Ibuprofen Sales Growth Rate Forecast (2021-2026) (MT)
Figure 128. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
Figure 1. Intravenous (IV) Ibuprofen Product Picture
Figure 2. Global Intravenous (IV) Ibuprofen Sales Market Share by Type in 2020 & 2026
Figure 3. 100 mg Dose Product Picture
Figure 4. 200 mg Dose Product Picture
Figure 5. 400 mg Dose Product Picture
Figure 6. 800 mg Dose Product Picture
Figure 7. Global Intravenous (IV) Ibuprofen Sales Market Share by Application in 2020 & 2026
Figure 8. Pain
Figure 9. Fever
Figure 10. Inflammation
Figure 11. Intravenous (IV) Ibuprofen Report Years Considered
Figure 12. Global Intravenous (IV) Ibuprofen Market Size 2015-2026 (US$ Million)
Figure 13. Global Intravenous (IV) Ibuprofen Sales 2015-2026 (MT)
Figure 14. Global Intravenous (IV) Ibuprofen Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Intravenous (IV) Ibuprofen Sales Market Share by Region (2015-2020)
Figure 16. Global Intravenous (IV) Ibuprofen Sales Market Share by Region in 2019
Figure 17. Global Intravenous (IV) Ibuprofen Revenue Market Share by Region (2015-2020)
Figure 18. Global Intravenous (IV) Ibuprofen Revenue Market Share by Region in 2019
Figure 19. Global Intravenous (IV) Ibuprofen Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Intravenous (IV) Ibuprofen Revenue in 2019
Figure 21. Intravenous (IV) Ibuprofen Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Intravenous (IV) Ibuprofen Sales Market Share by Type (2015-2020)
Figure 23. Global Intravenous (IV) Ibuprofen Sales Market Share by Type in 2019
Figure 24. Global Intravenous (IV) Ibuprofen Revenue Market Share by Type (2015-2020)
Figure 25. Global Intravenous (IV) Ibuprofen Revenue Market Share by Type in 2019
Figure 26. Global Intravenous (IV) Ibuprofen Market Share by Price Range (2015-2020)
Figure 27. Global Intravenous (IV) Ibuprofen Sales Market Share by Application (2015-2020)
Figure 28. Global Intravenous (IV) Ibuprofen Sales Market Share by Application in 2019
Figure 29. Global Intravenous (IV) Ibuprofen Revenue Market Share by Application (2015-2020)
Figure 30. Global Intravenous (IV) Ibuprofen Revenue Market Share by Application in 2019
Figure 31. North America Intravenous (IV) Ibuprofen Sales Growth Rate 2015-2020 (MT)
Figure 32. North America Intravenous (IV) Ibuprofen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Intravenous (IV) Ibuprofen Sales Market Share by Country in 2019
Figure 34. North America Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2019
Figure 35. U.S. Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 36. U.S. Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 38. Canada Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Intravenous (IV) Ibuprofen Market Share by Type in 2019
Figure 40. North America Intravenous (IV) Ibuprofen Market Share by Application in 2019
Figure 41. Europe Intravenous (IV) Ibuprofen Sales Growth Rate 2015-2020 (MT)
Figure 42. Europe Intravenous (IV) Ibuprofen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Intravenous (IV) Ibuprofen Sales Market Share by Country in 2019
Figure 44. Europe Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2019
Figure 45. Germany Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 46. Germany Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 48. France Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 50. U.K. Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 52. Italy Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 54. Russia Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Intravenous (IV) Ibuprofen Market Share by Type in 2019
Figure 56. Europe Intravenous (IV) Ibuprofen Market Share by Application in 2019
Figure 57. Asia Pacific Intravenous (IV) Ibuprofen Sales Growth Rate 2015-2020 (MT)
Figure 58. Asia Pacific Intravenous (IV) Ibuprofen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Intravenous (IV) Ibuprofen Sales Market Share by Region in 2019
Figure 60. Asia Pacific Intravenous (IV) Ibuprofen Revenue Market Share by Region in 2019
Figure 61. China Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 62. China Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 64. Japan Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 66. South Korea Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 68. India Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 70. Australia Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 72. Taiwan Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 74. Indonesia Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 76. Thailand Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 78. Malaysia Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 80. Philippines Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 82. Vietnam Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Intravenous (IV) Ibuprofen Market Share by Type in 2019
Figure 84. Asia Pacific Intravenous (IV) Ibuprofen Market Share by Application in 2019
Figure 85. Latin America Intravenous (IV) Ibuprofen Sales Growth Rate 2015-2020 (MT)
Figure 86. Latin America Intravenous (IV) Ibuprofen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Intravenous (IV) Ibuprofen Sales Market Share by Country in 2019
Figure 88. Latin America Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2019
Figure 89. Mexico Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 90. Mexico Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 92. Brazil Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 94. Argentina Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Intravenous (IV) Ibuprofen Market Share by Type in 2019
Figure 96. Latin America Intravenous (IV) Ibuprofen Market Share by Application in 2019
Figure 97. Middle East and Africa Intravenous (IV) Ibuprofen Sales Growth Rate 2015-2020 (MT)
Figure 98. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Intravenous (IV) Ibuprofen Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Market Share by Country in 2019
Figure 101. Turkey Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 102. Turkey Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 104. Saudi Arabia Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Intravenous (IV) Ibuprofen Sales Growth Rate (2015-2020) (MT)
Figure 106. U.A.E Intravenous (IV) Ibuprofen Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Intravenous (IV) Ibuprofen Market Share by Type in 2019
Figure 108. Middle East and Africa Intravenous (IV) Ibuprofen Market Share by Application in 2019
Figure 109. Cumberland Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Alveda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Sandor Medicaids Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. PT. Soho Industri Pharmasi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Germin MED Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Grifols Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Gloria Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. Al Nabeel International Total Revenue (US$ Million): 2019 Compared with 2018
Figure 118. Laboratorios Valmorca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 119. North America Intravenous (IV) Ibuprofen Sales Growth Rate Forecast (2021-2026) (MT)
Figure 120. North America Intravenous (IV) Ibuprofen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Europe Intravenous (IV) Ibuprofen Sales Growth Rate Forecast (2021-2026) (MT)
Figure 122. Europe Intravenous (IV) Ibuprofen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Asia Pacific Intravenous (IV) Ibuprofen Sales Growth Rate Forecast (2021-2026) (MT)
Figure 124. Asia Pacific Intravenous (IV) Ibuprofen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Latin America Intravenous (IV) Ibuprofen Sales Growth Rate Forecast (2021-2026) (MT)
Figure 126. Latin America Intravenous (IV) Ibuprofen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Middle East and Africa Intravenous (IV) Ibuprofen Sales Growth Rate Forecast (2021-2026) (MT)
Figure 128. Middle East and Africa Intravenous (IV) Ibuprofen Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 129. Porter's Five Forces Analysis
Figure 130. Channels of Distribution
Figure 131. Distributors Profiles
Figure 132. Bottom-up and Top-down Approaches for This Report
Figure 133. Data Triangulation
Figure 134. Key Executives Interviewed
